THE EFFECTS OF HPV VACCİNATİON AND MESSAGE FRAMİNG
THE EFFECT OF GAIN AND LOSS FRAMING MESSAGES ON RISK PERCEPTION AND KNOWLEDGE LEVELS REGARDING HPV VACCINATION AMONG UNIVERSITY STUDENTS: A RANDOMIZED CONTROLLED TRIAL
Background: University students are at high risk for HPV infection, while HPV vaccination rates remain low. Message framing strategies may influence vaccination-related perceptions and intentions.
Objective: This study aims to compare the effects of gain- and loss-framed HPV vaccination messages on HPV risk perception, HPV knowledge, and vaccination intention among university students.
Methods: This randomized controlled experimental study includes university students from the health sciences faculty of a foundation university. Participants are assigned to gain-framed, loss-framed, and control groups. Data are collected using the Human Papillomavirus Knowledge Scale and the HPV Risk Perception Questionnaire. Statistical analyses include one-way ANOVA, two-way ANOVA, and Chi-square tests. The study is designed in accordance with CONSORT 2010 and EQUATOR Network reporting guidelines.
Keywords: message framing; gain-loss framing; human papillomavirus; vaccination
研究概览
地位
详细说明
This randomized controlled experimental study examines the effects of gain- and loss-framed HPV vaccination messages on university students' HPV knowledge, risk perception, and vaccination intention. A total of 927 university students were assigned to gain-framed, loss-framed, and control groups. The study evaluates the relationship between message framing and vaccination-related outcomes among university students.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Ankara
-
Ankara、Ankara、土耳其（türkiye）、06000
- Ankara Medipol Üniversitesi
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Aged 18 years or older
- Voluntarily agrees to participate in the study
- Has not received formal education about HPV through a course or class
Exclusion Criteria:
- Has received the HPV vaccine
- Has participated in formal education about HPV through a course or class
- Has a current or previous positive HPV test result or HPV diagnosis
学习计划
研究是如何设计的？
设计细节
- 主要用途：预防
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Gain-Framed Group
Participants received gain-framed HPV vaccination messages. |
Participants received gain-framed messages emphasizing the benefits of HPV vaccination. |
|
实验性的：Loss-Framed Group
Participants received loss-framed HPV vaccination messages. |
Participants received loss-framed messages emphasizing the consequences of not receiving HPV vaccination. |
|
无干预：Control Group
Participants did not receive framed HPV vaccination messages. |
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
HPV Knowledge Level
大体时间：Before intervention and immediately after message exposure
|
HPV knowledge level will be assessed using the Human Papillomavirus Knowledge Scale (HPVKS), a 33-item scale evaluating knowledge about HPV infection, screening tests, and vaccination. Total scores range from 0 to 33, with higher scores indicating higher HPV-related knowledge levels. |
Before intervention and immediately after message exposure
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
HPV Risk Perception
大体时间：Before intervention and immediately after message exposure
|
HPV risk perception will be assessed using a 10-item Likert-type HPV Risk Perception Questionnaire developed based on the literature and expert opinion. Total scores range from 0 to 40, with higher scores indicating higher perceived risk related to HPV infection and HPV-associated diseases. |
Before intervention and immediately after message exposure
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- AMU-EBE-2025-173
- AMU-EBE-2025-173 (其他标识符：Ankara Medipol University Clinical Research Ethics Committee)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
Individual participant data will not be publicly shared in order to protect participant confidentiality and privacy.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.